These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22595372)

  • 1. Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools.
    Di Carlo M; Giacomazza D; San Biagio PL
    J Phys Condens Matter; 2012 Jun; 24(24):244102. PubMed ID: 22595372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Road to Alzheimer's disease: the pathomechanism underlying.
    Anand R; Kaushal A; Wani WY; Gill KD
    Pathobiology; 2012; 79(2):55-71. PubMed ID: 22205086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: a general introduction and pathomechanism.
    Finder VH
    J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.
    Bates KA; Verdile G; Li QX; Ames D; Hudson P; Masters CL; Martins RN
    Mol Psychiatry; 2009 May; 14(5):469-86. PubMed ID: 18794889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta and APP as biomarkers for Alzheimer's disease.
    Zetterberg H; Blennow K; Hanse E
    Exp Gerontol; 2010 Jan; 45(1):23-9. PubMed ID: 19698775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and the quest for its biological measures.
    Praticò D
    J Alzheimers Dis; 2013; 33 Suppl 1():S237-41. PubMed ID: 22695619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
    Wang YJ; Zhou HD; Zhou XF
    Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular biomarkers for early detection of Alzheimer's disease.
    Frost S; Martins RN; Kanagasingam Y
    J Alzheimers Dis; 2010; 22(1):1-16. PubMed ID: 20847434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sink hypothesis and therapeutic strategies for attenuating Abeta levels.
    Zhang Y; Lee DH
    Neuroscientist; 2011 Apr; 17(2):163-73. PubMed ID: 21330304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The link between altered cholesterol metabolism and Alzheimer's disease.
    Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
    Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.
    Brambilla D; Le Droumaguet B; Nicolas J; Hashemi SH; Wu LP; Moghimi SM; Couvreur P; Andrieux K
    Nanomedicine; 2011 Oct; 7(5):521-40. PubMed ID: 21477665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and the amyloid β-protein.
    Walsh DM; Teplow DB
    Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.